Nathan Hari, Cameron John L, Choti Michael A, Schulick Richard D, Pawlik Timothy M
Department of Surgery, The Johns Hopkins University School of Medicine, Baltimore, MD, USA.
J Am Coll Surg. 2009 Apr;208(4):528-38. doi: 10.1016/j.jamcollsurg.2009.01.007.
Although the relationship between hepato-pancreato-biliary (HPB) procedure volume and outcomes is established, the relative importance of hospital and surgeon effects and the specificity of the volume-outcomes effect remain ill-defined. We sought to comprehensively characterize the hospital and surgeon volume-outcomes relationships in high-risk HPB surgery.
The 1998 to 2005 State Inpatient Databases for Florida, Maryland, and New York were used to identify patients undergoing complex HPB surgery and to quantify hospital and surgeon procedure volumes. The effects of hospital and surgeon procedure volumes on casemix-adjusted inpatient mortality were analyzed using multilevel logistic regression models.
For hepatic resection, hospital procedure volume predicted mortality (high versus low volume, odds ratio [OR] 0.48, p=0.04), but surgeon volume did not (p=0.42). For pancreatic resection, in contrast, both hospital (OR 0.32, p < 0.001) and surgeon (OR 0.30, p < 0.001) procedure volume predicted mortality. The hospital volume effect for pancreatic resection was largely explained by surgeon volume. In both procedure groups, volume-outcomes effects were very specific. Only volumes of the primary procedure were predictive of mortality; volumes of related HPB procedures and overall HPB volume demonstrated no independent effect on mortality.
In HPB surgery, the relative contributions of hospital versus surgeon volume vary according to the specific procedure in question. In addition, the association between hospital or surgeon volume and in-hospital mortality is very specific to the procedure in question. High-volume expertise in one area of HPB surgery does not translate into improved outcomes for related procedures. These data may have implications for quality assessment and improvement, patient referral, and HPB surgical training.
尽管肝胰胆(HPB)手术量与手术结果之间的关系已得到证实,但医院和外科医生的影响的相对重要性以及手术量-结果效应的特异性仍不明确。我们试图全面描述高危HPB手术中医院和外科医生手术量与结果之间的关系。
利用佛罗里达州、马里兰州和纽约州1998年至2005年的住院患者数据库,识别接受复杂HPB手术的患者,并对医院和外科医生的手术量进行量化。使用多水平逻辑回归模型分析医院和外科医生手术量对病例组合调整后的住院死亡率的影响。
对于肝切除术,医院手术量可预测死亡率(高手术量与低手术量相比,优势比[OR]为0.48,p=0.04),但外科医生手术量则不能(p=0.42)。相比之下,对于胰腺切除术,医院(OR 0.32,p<0.001)和外科医生(OR 0.30,p<0.001)的手术量均能预测死亡率。胰腺切除术的医院手术量效应在很大程度上由外科医生手术量解释。在两个手术组中,手术量-结果效应都非常具有特异性。只有主要手术的手术量可预测死亡率;相关HPB手术的手术量和总体HPB手术量对死亡率无独立影响。
在HPB手术中,医院与外科医生手术量的相对贡献因具体手术而异。此外,医院或外科医生手术量与住院死亡率之间的关联非常特定于所讨论的手术。HPB手术一个领域的高手术量专业知识并不能转化为相关手术更好的结果。这些数据可能对质量评估与改进、患者转诊以及HPB外科培训有影响。